Exponent（EXPO）株式概要
エクスポネント社は、その子会社とともに、科学およびエンジニアリングのコンサルティング会社として、米国内外で事業を展開している。 詳細
EXPO Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Exponent, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$66.79 |
| 52週高値 | US$81.95 |
| 52週安値 | US$51.91 |
| ベータ | 0.68 |
| 1ヶ月の変化 | 7.55% |
| 3ヶ月変化 | 16.79% |
| 1年変化 | -4.22% |
| 3年間の変化 | -24.38% |
| 5年間の変化 | -41.82% |
| IPOからの変化 | 3,584.97% |
最新ニュース
Recent updates
Seeking Alpha • Jul 07
Exponent: AI Makes The Work More Complex, Not Less Valuable
Summary Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO’s value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO’s services, not diminish it. EXPO trades at ~24x NTM PE, appears historically cheap, and has upside if growth and margins outpace consensus as AI complexity accelerates. Read the full article on Seeking Alpha
ナラティブ更新 • Jul 07
EXPO: Share Repurchases And Premium Services Will Support Future Returns
Analysts have reduced the Exponent price target to $80 from $95 and now see fair value closer to $75, reflecting a higher discount rate, a lower future P/E assumption, and a focus on companies with more visible growth drivers in the current small cap industrials group. Analyst Commentary on Exponent Recent research updates on Exponent highlight a more cautious tone, with a cut to the price target and removal from a conviction list signaling that some investors are prioritizing other opportunities in the current small cap industrials group.
ナラティブ更新 • Jun 22
EXPO: AI Failure Analysis And Buybacks Will Support Premium Future P/E
Analysts have reduced their price target on Exponent to about $81.67 from $90, with recent target cuts to $80 citing macro uncertainty and a stronger preference for companies with resilient end markets and more visible growth drivers. Analyst Commentary Recent research on Exponent highlights a mix of optimism about the company’s positioning and caution around broader macro conditions, which is reflected in the reduced price targets around the US$80 level.
ナラティブ更新 • Jun 07
EXPO: Resilient End Markets And Buybacks Will Support Future Earnings Quality
Analysts have reduced their price target on Exponent to $80 from $95, citing a preference for stocks with more resilient end markets and clearer growth drivers in the current small-cap industrials group. Analyst Commentary Recent research highlights that while the price target on Exponent has been adjusted to US$80 from US$95, the stock still sits on the preferred list within the smaller cap industrials group.ナラティブ更新 • May 23
EXPO: Buybacks And Resilient End Markets Will Support Future Earnings Quality
Analysts have trimmed their fair value estimate for Exponent to $90 from $95, reflecting lower price targets in recent research and a stronger emphasis on selectivity in smaller cap industrials. Analyst Commentary Recent research points to a more selective stance on smaller cap industrials, with Exponent still viewed as a quality exposure for investors who prioritize resilient demand and clear growth drivers.ナラティブ更新 • May 03
EXPO: AI Failure Analysis And Buybacks Will Support Higher Earnings Quality
Analysts have adjusted their view on Exponent with a modest change to the price target in the $5 range, reflecting updated assumptions on growth, profitability and a slightly higher future P/E multiple informed by recent mixed revisions from JPMorgan and UBS. Analyst Commentary Recent commentary around Exponent highlights a mix of caution and optimism, with price targets adjusted within a narrow range and opinions split on the risk and reward at current levels.ナラティブ更新 • Apr 18
EXPO: AI Failure Analysis Demand Will Support Higher Earnings Quality
Analysts have adjusted the 12 month price target on Exponent to $95 from $90, reflecting updated assumptions around revenue growth, profit margins, and the P/E multiple they are willing to apply to future earnings. Analyst Commentary Recent Street research on Exponent has centered on how much investors are willing to pay for the company’s future earnings, with price targets adjusted as analysts revisit revenue assumptions, profit margins, and the P/E multiple.ナラティブ更新 • Apr 04
EXPO: AI Failure Analysis Work Will Sustain Premium P/E And Shareholder Returns
Analysts have trimmed their average price target for Exponent by $1.67 to reflect slightly lower fair value and profit margin assumptions, while still applying a relatively high future P/E multiple informed by recent mixed price target moves from JPMorgan and UBS. Analyst Commentary Recent Street research on Exponent reflects a mix of optimism about the business model and caution around valuation and near term execution, which is why price targets have moved in both directions.ナラティブ更新 • Mar 21
EXPO: AI Failure Analysis Work Will Support Margins And Shareholder Returns
Analysts have lifted their 12 month price target on Exponent by about $6 to around $92. This reflects updated expectations around revenue, margins and a slightly lower future P/E multiple following recent research updates from major firms.ナラティブ更新 • Mar 07
EXPO: Buybacks And Dividend Increases Will Support Future Shareholder Returns
Analysts nudged their price target on Exponent higher by $4, citing slightly firmer growth and margin assumptions, along with a modestly lower future P/E outlook as key supports for the revised view. Analyst Commentary Recent research coverage around Exponent has centered on how much investors should be willing to pay for the company relative to its growth and margin profile.ナラティブ更新 • Feb 20
EXPO: Raised UBS Target And Buybacks Will Support Higher Future P/E
Analysts have raised their price target on Exponent by $4 to $85, citing updated assumptions that include slightly lower revenue growth, a modestly higher discount rate, improved profit margin expectations, and a higher future P/E multiple. Analyst Commentary Recent Street research around Exponent highlights a mix of optimism and restraint, with the latest published work focusing on valuation inputs, growth expectations, and how much investors are willing to pay for the stock through the P/E multiple.分析記事 • Feb 09
Exponent (NASDAQ:EXPO) Is Increasing Its Dividend To $0.31
The board of Exponent, Inc. ( NASDAQ:EXPO ) has announced that the dividend on 20th of March will be increased to...ナラティブ更新 • Feb 06
EXPO: Bullish JPMorgan Initiation Will Support Confidence In Updated Fair Value Estimate
Analysts have raised their fair value estimate for Exponent from US$76.00 to US$81.00, citing updated assumptions for revenue growth, profit margins, and a slightly lower future P/E multiple in light of recent bullish Street research. Analyst Commentary Recent Street research, including a new bullish view from JPMorgan, has put more attention on how Exponent is priced and what could get in the way of the updated fair value estimate of US$81.00.ナラティブ更新 • Jan 23
EXPO: AI Failure Analysis Work Will Offset Automation Headwind Risks
Analysts have trimmed their price target on Exponent to US$90 from US$100, citing both the potential for increased AI driven failure analysis work and the offsetting risk that greater automation could reduce billable hours in consulting. Analyst Commentary Recent research points to a more balanced view on Exponent, with the reduced US$90 price target reflecting both potential upside from AI driven work and execution risks around automation in core consulting practices.ナラティブ更新 • Jan 09
EXPO: AI Failure Analysis Demand Will Support Future Consulting Engagements
Analysts have reduced their fair value estimate for Exponent to $90 from $100, citing a lower assumed future P/E multiple as they weigh the potential for AI-driven demand for failure analysis work against the risk that automation could reduce billable hours across the consulting sector. Analyst Commentary Recent commentary from bullish analysts centers on how AI adoption could shape Exponent's long term opportunity set, even as they factor in the risk that automation may cap billable hours across the consulting sector.分析記事 • Jan 08
What Exponent, Inc.'s (NASDAQ:EXPO) P/E Is Not Telling You
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 34.9x might make it look like a strong sell...ナラティブ更新 • Dec 16
EXPO: AI Failure Analysis Demand Will Outweigh Automation Efficiency Headwinds
Analysts have nudged their fair value estimate for Exponent higher to approximately $85.50 from $83.00 per share, citing the potential for AI driven demand in complex failure analysis work, while acknowledging that automation related efficiency gains could temper billable hours across the consulting industry. Analyst Commentary Bullish analysts highlight that the revised target still implies meaningful upside from current levels, even after a modest trim.ナラティブ更新 • Dec 01
EXPO: AI-Driven Demand Will Drive Future Engagements Despite Automation Headwinds
Analysts have revised Exponent's price target downward by $10 to $90 per share, citing potential opportunities from AI-driven engagements as well as industry headwinds related to automation efficiencies. Analyst Commentary Following the recent revision to Exponent's price target, analysts have highlighted both opportunities and risks facing the company in today's evolving market landscape.ナラティブ更新 • Nov 17
EXPO: AI-Driven Client Demand Will Offset Automation Concerns In Consulting
Exponent’s analyst price target has been reduced by $10 to $90, as analysts cite ongoing automation concerns that could impact the consulting sector. They also note potential opportunities from increased AI-driven client demand.分析記事 • Nov 02
Exponent, Inc. Just Beat EPS By 8.5%: Here's What Analysts Think Will Happen Next
A week ago, Exponent, Inc. ( NASDAQ:EXPO ) came out with a strong set of third-quarter numbers that could potentially...ナラティブ更新 • Nov 02
EXPO: Increased Buyback Will Drive Shareholder Returns In Coming Quarters
Narrative Update: Exponent Analyst Price Target Adjustment Analysts have lowered their price target for Exponent from $88 to $83. This change reflects updated expectations for revenue growth and profitability margins moving forward.分析記事 • Oct 06
Returns On Capital At Exponent (NASDAQ:EXPO) Have Stalled
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...分析記事 • Jul 30
A Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)
Key Insights Exponent's estimated fair value is US$63.97 based on 2 Stage Free Cash Flow to Equity Exponent's US$70.44...分析記事 • Jul 14
When Should You Buy Exponent, Inc. (NASDAQ:EXPO)?
Exponent, Inc. ( NASDAQ:EXPO ), might not be a large cap stock, but it received a lot of attention from a substantial...分析記事 • Jun 28
Exponent (NASDAQ:EXPO) Knows How To Allocate Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...分析記事 • May 27
Subdued Growth No Barrier To Exponent, Inc.'s (NASDAQ:EXPO) Price
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 36.7x might make it look like a strong sell...分析記事 • Apr 06
Is Exponent, Inc. (NASDAQ:EXPO) Potentially Undervalued?
Exponent, Inc. ( NASDAQ:EXPO ), might not be a large cap stock, but it saw significant share price movement during...分析記事 • Mar 22
Return Trends At Exponent (NASDAQ:EXPO) Aren't Appealing
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Seeking Alpha • Mar 10
Exponent: A Unique Dividend Contender That Is Valued At A Premium
Summary Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is at a premium, making Exponent a hold. The company's competitive advantages include its reputation, technical expertise, and long-term client relationships, ensuring continued market leadership. Exponent's dividend safety is excellent, supported by a conservative payout ratio and robust free cash flow, but the current valuation is a concern. Read the full article on Seeking Alpha分析記事 • Feb 13
Exponent's (NASDAQ:EXPO) Shareholders Will Receive A Bigger Dividend Than Last Year
Exponent, Inc.'s ( NASDAQ:EXPO ) dividend will be increasing from last year's payment of the same period to $0.30 on...分析記事 • Jan 30
Exponent, Inc.'s (NASDAQ:EXPO) Intrinsic Value Is Potentially 34% Above Its Share Price
Key Insights The projected fair value for Exponent is US$122 based on 2 Stage Free Cash Flow to Equity Exponent is...分析記事 • Dec 28
Risks To Shareholder Returns Are Elevated At These Prices For Exponent, Inc. (NASDAQ:EXPO)
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 42.7x might make it look like a strong sell...分析記事 • Dec 10
Here's What To Make Of Exponent's (NASDAQ:EXPO) Decelerating Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Nov 08
Exponent's (NASDAQ:EXPO) Earnings Seem To Be Promising
Despite posting healthy earnings, Exponent, Inc.'s ( NASDAQ:EXPO ) stock has been quite weak. Along with the solid...株主還元
| EXPO | US Professional Services | US 市場 | |
|---|---|---|---|
| 7D | -2.2% | 3.8% | 2.7% |
| 1Y | -4.2% | -11.7% | 20.9% |
業界別リターン: EXPO過去 1 年間で-11.7 % の収益を上げたUS Professional Services業界を上回りました。
リターン対市場: EXPOは、過去 1 年間で20.9 % のリターンを上げたUS市場を下回りました。
価格変動
| EXPO volatility | |
|---|---|
| EXPO Average Weekly Movement | 5.1% |
| Professional Services Industry Average Movement | 8.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: EXPO 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: EXPOの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1967 | 1,013 | Catherine Corrigan | www.exponent.com |
エクスポネント社は、その子会社とともに、科学・工学コンサルティング会社として米国内外で事業を展開している。同社はエンジニアリングとその他科学、環境と健康の2つのセグメントで事業を展開している。バイオメカニクス、生物医学工学・科学、土木・構造工学、建設コンサルティング、データサイエンス、電気工学・コンピューターサイエンス、ヒューマンファクター、材料・腐食工学、機械工学、冶金・腐食工学ポリマー・化学、熱科学、車両工学の分野でサービスを提供している。また、化学規制・食品安全、生態学・生物学、環境・地球科学、健康科学の分野でもサービスを提供している。さらに、事前・事後の製品安全、訴訟サポート、技術・規制サービスも提供している。化学、建設、消費者製品、エネルギー、食品・飲料・栄養、政府、ライフサイエンス、保険、製造、テクノロジー、産業機器、運輸、その他の分野の顧客にサービスを提供している。同社は以前はザ・フェイラー・グループ社として知られ、1998年にエクスポネント社に社名を変更した。同社は1967年に設立され、カリフォルニア州メンローパークに本社を置いている。
Exponent, Inc. 基礎のまとめ
| EXPO 基礎統計学 | |
|---|---|
| 時価総額 | US$3.18b |
| 収益（TTM） | US$111.77m |
| 売上高(TTM) | US$567.13m |
28.4x
PER（株価収益率5.6x
P/SレシオEXPO は割高か？
公正価値と評価分析を参照収益と収入
| EXPO 損益計算書（TTM） | |
|---|---|
| 収益 | US$567.13m |
| 売上原価 | US$360.60m |
| 売上総利益 | US$206.54m |
| その他の費用 | US$94.77m |
| 収益 | US$111.77m |
直近の収益報告
Jul 03, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | 2.35 |
| グロス・マージン | 36.42% |
| 純利益率 | 19.71% |
| 有利子負債／自己資本比率 | 0% |
EXPO の長期的なパフォーマンスは？
過去の実績と比較を見る| Exponent 配当日 | |
|---|---|
| 配当落ち日 | Sep 04 2026 |
| 配当支払日 | Sep 18 2026 |
| 配当落ちまでの日数 | 24 days |
| 配当支払日までの日数 | 38 days |
EXPO 配当は確実ですか？
EXPO 配当履歴とベンチマークを見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/08/10 13:28 |
| 終値 | 2026/08/07 00:00 |
| 収益 | 2026/07/03 |
| 年間収益 | 2026/01/02 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Exponent, Inc. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7
| アナリスト | 機関 |
|---|---|
| Joseph Foresi | Brean Capital Historical (Janney Montgomery) |
| Alexis Huseby | D.A. Davidson & Co. |
| Tomohiko Sano | J.P. Morgan |